Cited by 479Advanced X-ray and CT ImagingCardiac Imaging and DiagnosticsAtherosclerosis and Cardiovascular Diseases

Atherosclerotic Plaque Composition: Analysis with Multicolor CT and Targeted Gold Nanoparticles

Open access
Cormode, David P., Roessl, Ewald, Thran, Axel, Skajaa, Torjus, Gordon, Ronald E., Schlomka, Jens-Peter, Fuster, Valentin, Fisher, Edward A. +3 more·2010·Radiology

Abstract

PURPOSE: To investigate the potential of spectral computed tomography (CT) (popularly referred to as multicolor CT), used in combination with a gold high-density lipoprotein nanoparticle contrast agent (Au-HDL), for characterization of macrophage burden, calcification, and stenosis of atherosclerotic plaques. MATERIALS AND METHODS: The local animal care committee approved all animal experiments. A preclinical spectral CT system in which incident x-rays are divided into six different energy bins was used for multicolor imaging. Au-HDL, an iodine-based contrast agent, and calcium phosphate were imaged in a variety of phantoms. Apolipoprotein E knockout (apo E-KO) mice were used as the model for atherosclerosis. Gold nanoparticles targeted to atherosclerosis (Au-HDL) were intravenously injected at a dose of 500 mg per kilogram of body weight. Iodine-based contrast material was injected 24 hours later, after which the mice were imaged. Wild-type mice were used as controls. Macrophage targeting by Au-HDL was further evaluated by using transmission electron microscopy and confocal microscopy of aorta sections. RESULTS: Multicolor CT enabled differentiation of Au-HDL, iodine-based contrast material, and calcium phosphate in the phantoms. Accumulations of Au-HDL were detected in the aortas of the apo E-KO mice, while the iodine-based contrast agent and the calcium-rich tissue could also be detected and thus facilitated visualization of the vasculature and bones (skeleton), respectively, during a single scanning examination. Microscopy revealed Au-HDL to be primarily localized in the macrophages on the aorta sections; hence, the multicolor CT images provided information about the macrophage burden. CONCLUSION: Spectral CT used with carefully chosen contrast agents may yield valuable information about atherosclerotic plaque composition.

Integrity signals

Registry

Crossref · 10.1148/radiol.10092473

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multicolour CT imaging allows identification of macrophage-rich atherosclerotic lesions in APOE-knockout mice.

    “A gold-core version of the nanocrystal HDL platform mentioned above, which was previously shown — using MRI — to accumulate in plaques137, and an iodine-based blood-pool agent were injected simultaneously into APOE-knockout mice and clearly showed that multicolour CT imaging allows the identification of macrophage-rich atherosclerotic lesions142 (FIG. 6a).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cormode, D. P., Roessl, E., Thran, A., Skajaa, T., Gordon, R. E., Schlomka, J.-P., Fuster, V., Fisher, E. A., Mulder, W. J. M., Proksa, R., & Fayad, Z. A.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • Philips (Germany) (DE)
  • Mount Sinai Hospital (US)
  • New York University (US)
Venue
Radiology
Published
2010-09
Volume
256
Issue
3
Pages
774-782
ISSN
  • 0033-8419 (ISSN-L)
  • 1527-1315
OpenAlex
W2105050495
Cited by
479
References
43
Citations by year
2026: 6 · 2025: 17 · 2024: 21 · 2023: 34 · 2022: 27 · 2021: 37 · 2020: 41 · 2019: 31 · 2018: 36 · 2017: 37 · 2016: 28 · 2015: 30 · 2014: 40 · 2013: 34 · 2012: 33
FWCI
17.74
Type
journal article
Language
en
Open access
Locations
  • Radiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL061814, R01 HL 71021, R01HL078667, R01HL071021, R01 HL61814, R01 HL 78667)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB009638, K99EB012165)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Advanced X-ray and CT Imaging
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
atherosclerotic plaque composition, spectral computed tomography, gold nanoparticles, plaque calcification, iodinated contrast media, calcium phosphate, ApoE-deficient mice, atherosclerosis imaging
MeSH terms
Animals, Aortic Diseases, Color, Contrast Media, Gold, Iodine, Microscopy, Electron, Tomography, X-Ray Computed, Mice, Knockout, Microscopy, Confocal, Phantoms, Imaging, Atherosclerosis, Mice, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review